Put up against placebo in the phase 3 EMBARK trial, delandistrogene moxeparvovec (Elevidys) did not significantly improve ...

Sydney technology company Devicie said it has signed an exclusive partnership with managed service provider Entag of the ...

Ivanti Neurons is an all-in-one IT asset management and RMM tool perfect for large businesses and MSPs. Its excellent ...

Almost half of adults and children with neurofibromatosis type 1 (NF1) responded to the investigational MEK inhibitor ...

Eyenovia’s stock craters to its lowest point in its six-year lifespan as a public company following the biotech’s termination ...

While for many others deciding to pursue a specific career path doesn't come until college, BYU student Ian Atkin's ...

Boston Pharmaceuticals has linked its metabolic dysfunction-associated steatohepatitis (MASH) prospect to improved outcomes ...

A review of study data by an independent Data Review Committee found that CHAPERONE is not meeting its primary three-year efficacy endpoint Company to discontinue study, review full data set, and ...

Is Palantir the best software stock to purchase between the two? Or is CrowdStrike the better option here? Start Your ...

The annual fundraiser is back for another year with a host of famous presenters live from Salford's MediaCityUK ...

Cybersecurity has become a critical issue for individuals and organizations of all sizes. According to Gartner, the global ...

As the maritime industry becomes increasingly digitized, it also becomes more vulnerable to damaging cyberattacks.